{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:28:59Z","timestamp":1786994939923,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.neurol.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T03:55:01Z","timestamp":1587354901000},"page":"507-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network"],"prefix":"10.1016","volume":"176","author":[{"given":"G.","family":"Sol\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Pereon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Laforet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tiffreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Desguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.I.","family":"Pisella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Molon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Attarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.04.004_bib0210","series-title":"Recommandation r\u00e9gionales COVID-19","author":"Agence R\u00e9gionale de Sant\u00e9 \u00cele-de-France","year":"2020"},{"key":"10.1016\/j.neurol.2020.04.004_bib0215","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2018.1314","article-title":"The role of telehealth in the medical response to disasters","volume":"178","author":"Lurie","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0220","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamaneurol.2014.3844","article-title":"Advantages and limitations of teleneurology","volume":"72","author":"Wechsler","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.04.004_bib0225","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JND-160185","article-title":"European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences","volume":"3","author":"Vry","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.neurol.2020.04.004_bib0230","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.0000000000001416","volume":"84","author":"Kang","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.04.004_bib0235","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4006","article-title":"Implementation of Duchenne muscular dystrophy care considerations","volume":"142","author":"Andrews","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.neurol.2020.04.004_bib0240","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1542\/peds.2018-0333J","article-title":"Orthopedic and surgical management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Apkon","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.neurol.2020.04.004_bib0245","first-page":"CD003907","article-title":"Strength training and aerobic exercise training for muscle disease","volume":"12","author":"Voet","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2020.04.004_bib0250","series-title":"\u00c9pid\u00e9mie \u00e0 COVID-19\u00a0: accompagnement des personnes en situation de handicap","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2020"},{"key":"10.1016\/j.neurol.2020.04.004_bib0255","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-014-7402-z","article-title":"Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis","volume":"261","author":"Hundsberger","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.04.004_bib0260","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1007\/s00415-018-9065-7","article-title":"36-months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry","volume":"265","author":"Scheidegger","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.04.004_bib0265","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neurol.2020.04.004_bib0270","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.neurol.2020.04.004_bib0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-015-0326-6","article-title":"Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study","volume":"10","author":"Suhr","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurol.2020.04.004_bib0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.26711","article-title":"Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: new and novel agents","volume":"61","author":"Farmakidis","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2020.04.004_bib0290","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.04.004_bib0295","doi-asserted-by":"crossref","first-page":"116428","DOI":"10.1016\/j.jns.2019.116428","article-title":"Myasthenia gravis: historical achievements and the \u201cgolden age\u201d of clinical trials","volume":"406","author":"Nguyen-Cao","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2020.04.004_bib0300","doi-asserted-by":"crossref","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"International MG\/COVID-19 Working Group","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2020.04.004_bib0305","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0310","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0315","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurol.2020.04.004_bib0320","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.neurol.2020.04.004_bib0325","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0330","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0335","series-title":"Position statement of the ESC Council on hypertension on ACE inhibitors and angiotensin receptor blockers","author":"European Society of Cardiology","year":"2020"},{"key":"10.1016\/j.neurol.2020.04.004_bib0340","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.neurol.2020.04.004_bib0345","series-title":"GeneReviews\u00ae","article-title":"Congenital myasthenic syndromes","author":"Abicht","year":"1993"},{"key":"10.1016\/j.neurol.2020.04.004_bib0350","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mus.26689","article-title":"Factors associated with acute exacerbations of myasthenia gravis","volume":"60","author":"Gummi","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2020.04.004_bib0355","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.04.004_bib0360","first-page":"849","article-title":"Myasthenia gravis due to hydroxychloroquine","volume":"67","author":"Varan","year":"2015","journal-title":"Reumatismo"},{"key":"10.1016\/j.neurol.2020.04.004_bib0365","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2020.04.004_bib0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0375","unstructured":"SFAR. Comit\u00e9 \u00e9thique\u00a0: \u00e0 propos des d\u00e9cisions m\u00e9dicales d\u2019admission des patients en unit\u00e9 de soins critiques en contexte pand\u00e9mique\u00a0: quelques rep\u00e8res \u00e9thiques. n.d. https:\/\/sfar.org\/download\/comite-ethique-a-propos-des-decisions-medicales-dadmission-des-patients-en-unite-de-soins-critiques-en-context-pandemique-quelques-reperes-ethiques\/."},{"key":"10.1016\/j.neurol.2020.04.004_bib0380","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.neurol.2020.04.004_bib0385","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/CCM.0000000000000860","article-title":"Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study","volume":"43","author":"Bagshaw","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0390","first-page":"e0066","article-title":"Clinical Frailty Scale Score before ICU admission is associated with mobility disability in septic patients receiving early rehabilitation","volume":"1","author":"Nakajima","year":"2019","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.neurol.2020.04.004_bib0395","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2213-2600(20)30084-9","article-title":"Staff safety during emergency airway management for COVID-19 in Hong Kong","volume":"8","author":"Cheung","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.neurol.2020.04.004_bib0400","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02339-2018","article-title":"Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks","volume":"53","author":"Hui","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.neurol.2020.04.004_bib0405","series-title":"Recommandations d\u2019experts portant sur la prise en charge en r\u00e9animation des patients en p\u00e9riode d\u2019\u00e9pid\u00e9mie \u00e0 SARS-CoV2","author":"SRLF-SFAR-SFMU-GFRUP-SPILF","year":"2020"},{"key":"10.1016\/j.neurol.2020.04.004_bib0410","series-title":"Appareillages respiratoires de domicile d\u2019un malade suspect ou porteur du de virus respiratoire","author":"Groupe assistance ventilatoire et oxyg\u00e8ne","year":"2020"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:40:50Z","timestamp":1758519650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720305233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0035378720305233"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.04.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}